Key result
Surgical treatment for post-infarction papillary muscle rupture carried a 24.8% in-hospital mortality rate, though concomitant coronary artery bypass grafting improved early survival (OR 0.38; 95% CI 0.16-0.92).
Why the study?
Papillary muscle rupture is a rare but potentially fatal complication of acute myocardial infarction, prompting this analysis of patient characteristics and early outcomes of its surgical management.
Does concomitant coronary artery bypass grafting improve early survival in patients undergoing surgery for post-infarction papillary muscle rupture?
Observational (n=214)
Yes
Does concomitant coronary artery bypass grafting improve early survival in patients undergoing surgery for post-infarction papillary muscle rupture?
Surgical treatment for post-infarction papillary muscle rupture carries a high in-hospital mortality of 24.8%, but performing concomitant CABG when possible may confer a survival benefit.
OBJECTIVES: Papillary muscle rupture (PMR) is a rare but potentially fatal complication of acute myocardial infarction. The aim of this study was to analyse the patient characteristics and early outcomes of the surgical management of post-infarction PMR from an international multicentre registry. METHODS: Patients underwent surgery for post-infarction PMR between 2001 through 2019 were retrieved from database of the CAUTION study. The primary end point was in-hospital mortality. RESULTS: A total of 214 patients were included with a mean age of 66.9 (standard deviation: 10.5) years. The posteromedial papillary muscle was the most frequent rupture location (71.9%); the rupture was complete in 67.3% of patients. Mitral valve replacement was performed in 82.7% of cases. One hundred twenty-two patients (57%) had concomitant coronary artery bypass grafting. In-hospital mortality was 24.8%. Temporal trends revealed no apparent improvement in in-hospital mortality during the study period. Multivariable analysis showed that preoperative chronic kidney disfunction [odds ratio (OR): 2.62, 95% confidence interval (CI): 1.07-6.45, P = 0.036], cardiac arrest (OR: 3.99, 95% CI: 1.02-15.61, P = 0.046) and cardiopulmonary bypass duration (OR: 1.01, 95% CI: 1.00-1.02, P = 0.04) were independently associated with an increased risk of in-hospital death, whereas concomitant coronary artery bypass grafting was identified as an independent predictor of early survival (OR: 0.38, 95% CI: 0.16-0.92, P = 0.031). CONCLUSIONS: Surgical treatment for post-infarction PMR carries a high in-hospital mortality rate, which did not improve during the study period. Because concomitant coronary artery bypass grafting confers a survival benefit, this additional procedure should be performed, whenever possible, in an attempt to improve the outcome. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov: NCT03848429.
No takes yet. Share an insight, caveat, or question.
Massimi et al. (2021) conducted an observational in Post-infarction papillary muscle rupture (n=214). Surgical treatment (with or without concomitant coronary artery bypass grafting) was evaluated on In-hospital mortality. Surgical treatment for post-infarction papillary muscle rupture carried a 24.8% in-hospital mortality rate, though concomitant coronary artery bypass grafting improved early survival (OR 0.38; 95% CI 0.16-0.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: